The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

MIRM FINANCIAL STATEMENTS

Mirum Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

MIRMMirum Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-500 M0500 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue618.1 M $Gross Profit505 M $ · 82%Operating Income-107.7 M $ · -17%Pre-tax Income-857.5 M $ · -139%Net Income to Owners-860.2 M $ · -139%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue618.1 M $+44.0%
Gross Profit505 M $+48.9%
Operating Income-107.7 M $—
EBITDA-776.8 M $—
Net Income to Owners-860.2 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets1 B
  • Current Liabilities222.8 M $21%
  • Long-term Liabilities832.6 M $79%

Key Figures

YoY change
Total Assets1 B $+44.0%
Total Liabilities1.1 B $+124.2%
Total Equity-10.4 M $-104.1%
Cash & ST Investments438.3 M $+43.9%
Total Debt760.5 M $+138.5%
Net Debt429.8 M $+373.5%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-400 M-200 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-500 M-250 M0-456 M $Operating-184.4 M $Investing776.7 M $Financing136.3 M $Net Change

Key Figures

YoY change
Operating Cash Flow-456 M $-5,169.8%
Capital Expenditures2.1 M $-79.4%
Free Cash Flow-458.2 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on MIRM

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.